A 67-Year-Old Man With NTRK Fusion-Positive Metastatic Lung Cancer
EP. 1: Case of an NTRK Fusion-Positive Lung Cancer Patient
By
Luis E. Raez, MD
April 22nd 2020
EP. 2: Testing in NTRK Fusion-Positive Lung Cancer
By
Luis E. Raez, MD
April 22nd 2020
EP. 3: Treatment in NTRK Fusion-Positive Lung Cancer
By
Luis E. Raez, MD
April 22nd 2020
EP. 4: Targeted Treatment in NTRK Fusion-Positive Cancer
By
Luis E. Raez, MD
April 22nd 2020
EP. 5: Larotrectinib in NTRK Fusion-Positive Lung Cancer
By
Luis E. Raez, MD
April 22nd 2020
EP. 6: Response to Treatment With Larotrectinib
By
Luis E. Raez, MD
April 22nd 2020
EP. 7: Management of Toxicities of Larotrectinib
By
Luis E. Raez, MD
April 22nd 2020
EP. 8: Treatment Resistance Due to Gene Mutation
By
Luis E. Raez, MD
April 22nd 2020
EP. 9: Larotrectinib: A Tumor-Agnostic Therapy
By
Luis E. Raez, MD
April 22nd 2020
